August 17, 2022
A New Jersey federal judge on Wednesday tossed a proposed class action accusing Endo International PLC — which yesterday filed for Chapter 11 protection — of misleading investors about its role in the opioid crisis, saying the shareholders haven't shown the company's statements were misleading or caused their losses.
September 01, 2021
A New Jersey federal judge has tossed a proposed class action against Endo International PLC over claims it misled investors about its role in the opioid crisis, finding the investors failed to show how the drugmaker defrauded them.
September 28, 2020
A New Jersey federal judge on Monday signed off on a lead plaintiff and lead counsel Pomerantz LLP in a proposed class action against Endo International PLC over claims the drugmaker misled investors about its role in the opioid crisis.
August 19, 2020
Glancy Prongay & Murray LLP, Pomerantz LLP, Levi & Korsinsky LLP and Bragar Eagel & Squire PC have launched competing bids to steer a proposed class action against Endo International PLC in New Jersey federal court over claims the drugmaker misled investors about its role in the opioid crisis.
June 22, 2020
An Endo International PLC investor launched a proposed class action Monday claiming the drugmaker's stock dropped nearly 15% after allegations surfaced about the company's role in New York's opioid crisis, unearthing a purported cover-up that left shareholders in the dark.